| name | Xeomin (incobotulinumtoxinA) |
| classification | Botulinum Toxin Type A |
| pharmacokinetics | Xeomin is a purified botulinum toxin type A. Following injection, it inhibits the release of acetylcholine at the neuromuscular junction, leading to temporary muscle relaxation. The precise pharmacokinetic profile varies depending on the specific application. The effects typically last for several months, with gradual return to baseline function. |
| suggested dosage | Dosage is determined by the treating physician based on the specific condition being treated and the patient's needs. It is not appropriate to provide a general dosage recommendation without a specific clinical context. Precise details should be obtained from the prescribing physician. Factors such as the specific area needing treatment, the extent of the condition, and the patient's response to treatment will determine the individual dose. |
| indications | | 1 | | category | Cosmetic | | conditions | | 1 | Moderate to severe frown lines | | 2 | Glabellar lines | | 3 | Crow's feet | | 4 | Other dynamic wrinkles |
|
| | 2 | | category | Medical | | conditions | | 1 | Blepharospasm | | 2 | Strabismus (eye muscle imbalance) | | 3 | Hyperhidrosis (excessive sweating) | | 4 | Certain muscle spasms |
|
|
|
| safety in pregnancy | Xeomin is not recommended for use during pregnancy. The safety and effectiveness of Xeomin in pregnant women have not been established. Consult with a physician before using any medication during pregnancy. |
| safety in breastfeeding | The safety of Xeomin in breastfeeding women is not well established. Avoid use if possible. It is essential to consult with a physician to weigh the potential risks and benefits of treatment. |
| side effects | | 1 | Temporary pain, redness, or swelling at the injection site | | 2 | Dry mouth | | 3 | Headache | | 4 | Muscle weakness (transient, usually mild) | | 5 | In rare cases, more serious side effects such as difficulty swallowing, breathing problems, or allergic reactions. | | 6 | Potential for spread of toxin to surrounding areas if injection technique is inappropriate. |
|
| alternatives | |
| contraindications | | 1 | Known allergy to botulinum toxin or any component of Xeomin | | 2 | Active infection at the injection site | | 3 | Uncontrolled neurological conditions | | 4 | Severe muscle weakness or neuromuscular disorders | | 5 | History of serious hypersensitivity reactions to botulinum toxins |
|
| interactions | Limited interaction information available. Xeomin is unlikely to interact significantly with other medications. It's crucial to disclose all medications, supplements, and herbal remedies to the healthcare provider. |
| warnings and precautions | | 1 | Xeomin should only be administered by a qualified healthcare professional with expertise in botulinum toxin injection. | | 2 | Careful evaluation of the patient's medical history, including any pre-existing muscle weakness or neurological conditions, is crucial before treatment. | | 3 | Follow-up appointments may be necessary to monitor treatment response and manage potential side effects. | | 4 | The decision to use Xeomin should be made in consultation with a physician experienced in its use. | | 5 | Avoid use in patients with uncontrolled systemic or local infections. |
|
| additional informations | Xeomin is a purified botulinum toxin type A. Proper injection technique is essential to minimize potential side effects. |
| patient details | |
